- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有16家主力机构披露2025-06-30报告期持股数据，持仓量总计6325.66万股，占流通A股51.97%
- 波段诊断：
-
技术面诊股
诊断结果：8.2技术面打败了85%的股票
技术面评分前10的股票
近期的平均成本为18.77元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为18.77元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"18.77","date":1761193611,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2025.10.23","stock":"-0.26","trade":"-0.36","ind":"0.22"},{"date":"2025.10.22","stock":"0.58","trade":"0.70","ind":"-0.07"},{"date":"2025.10.21","stock":"2.22","trade":"0.86","ind":"1.36"},{"date":"2025.10.20","stock":"0.38","trade":"0.20","ind":"0.63"},{"date":"2025.10.17","stock":"-5.30","trade":"-0.94","ind":"-1.95"},{"date":"2025.10.16","stock":"-0.97","trade":"0.75","ind":"0.10"},{"date":"2025.10.15","stock":"5.31","trade":"1.37","ind":"1.22"},{"date":"2025.10.14","stock":"2.59","trade":"0.32","ind":"-0.62"},{"date":"2025.10.13","stock":"-5.17","trade":"-0.86","ind":"-0.19"},{"date":"2025.10.10","stock":"4.36","trade":"1.31","ind":"-0.94"},{"date":"2025.10.09","stock":"0.49","trade":"0.26","ind":"1.32"},{"date":"2025.09.30","stock":"0.00","trade":"0.12","ind":"0.52"},{"date":"2025.09.29","stock":"-0.27","trade":"0.13","ind":"0.90"},{"date":"2025.09.26","stock":"-1.13","trade":"-0.51","ind":"-0.65"},{"date":"2025.09.25","stock":"-1.07","trade":"-0.70","ind":"-0.01"},{"date":"2025.09.24","stock":"0.65","trade":"1.12","ind":"0.83"},{"date":"2025.09.23","stock":"1.58","trade":"-1.40","ind":"-0.18"},{"date":"2025.09.22","stock":"2.29","trade":"-0.53","ind":"0.22"},{"date":"2025.09.19","stock":"-1.54","trade":"-1.04","ind":"-0.30"},{"date":"2025.09.18","stock":"-1.68","trade":"-1.21","ind":"-1.15"},{"date":"2025.09.17","stock":"0.11","trade":"-0.25","ind":"0.37"}]
天目药业,上证指数,中药指数
压力支撑
该股压力位为18.74元，支撑位为18.38元。
[{"text":"\u538b\u529b\u4f4d","value":"18.74","date":1761148800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.38","date":1761148800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.9资金面打败了18%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月24日 13:24
| 机构今日流向(万元) | -1702.06 | 机构5日流向(万元) | -2322.66 |
| 机构10日流向(万元) | -98.39 | 机构20日流向(万元) | -11928.76 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加224.42万股，其中基金数没有增加，主力净增仓12家，有一定的中长期投资价值。
截止2025-06-30，共16家主力机构（基金12家，一般法人4家），持仓量总计6325.66万股，占流通A股51.97%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：12家 ，持有39.53万股
从主力名单中消失：0家 ，原持有万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：12家 ，持有39.53万股
从主力名单中消失：0家 ，原持有万股
消息面诊股
诊断结果：5.9消息面打败了54%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 天目药业主力资金持续净流入，3日共净流入2480.
2025-10-17 - 2025前三季度杭州上市公司市值排行
2025-09-30 - 天目药业部分存货核销
2025-09-30 - 天目药业换发药品生产许可证
2025-09-30 - 天目药业战略转型显成效 营销+产能双轮驱动开启增长
2025-09-27 - 行业周报|中药指数跌-2.02%, 跑输上证指数2
2025-09-26 - 天目药业：加快推进珍珠明目滴眼液等优质产品的复产工
2025-09-25 - 天目药业（截止2025年9月19日）股东人数为10
2025-09-24 - 天目药业：子公司生产销售资质获延续
2025-09-22 - 天目药业：全资子公司获药品再注册批准通知书
2025-09-22
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-12 |
| 一般消息 | 高管变动 | 工作调动 | 2025-08-29 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-07-24 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-07-15 |
| 利好 | 上市变动 | 公司摘帽 | 2025-05-20 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-22 |
| 一般消息 | 高管变动 | 工作调动原因 | 2025-04-10 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-01 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-01-25 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-11-27 |
| 一般消息 | 重大事项 | 关联交易 | 2024-10-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：7.8行业面打败了95%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑赢大盘。
[{"date":"2025.10.23","price":"0.22","value":"-0.36"},{"date":"2025.10.22","price":"-0.07","value":"0.70"},{"date":"2025.10.21","price":"1.36","value":"0.86"},{"date":"2025.10.20","price":"0.63","value":"0.20"},{"date":"2025.10.17","price":"-1.95","value":"-0.94"},{"date":"2025.10.16","price":"0.10","value":"0.75"},{"date":"2025.10.15","price":"1.22","value":"1.37"},{"date":"2025.10.14","price":"-0.62","value":"0.32"},{"date":"2025.10.13","price":"-0.19","value":"-0.86"},{"date":"2025.10.10","price":"-0.94","value":"1.31"},{"date":"2025.10.09","price":"1.32","value":"0.26"},{"date":"2025.09.30","price":"0.52","value":"0.12"},{"date":"2025.09.29","price":"0.90","value":"0.13"},{"date":"2025.09.26","price":"-0.65","value":"-0.51"},{"date":"2025.09.25","price":"-0.01","value":"-0.70"},{"date":"2025.09.24","price":"0.83","value":"1.12"},{"date":"2025.09.23","price":"-0.18","value":"-1.40"},{"date":"2025.09.22","price":"0.22","value":"-0.53"},{"date":"2025.09.19","price":"-0.30","value":"-1.04"},{"date":"2025.09.18","price":"-1.15","value":"-1.21"},{"date":"2025.09.17","price":"0.37","value":"-0.25"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 27.63% | -3.43% | 6.1分 |
| 2 | 特一药业 | 22.44% | 20.25% | 6.2分 |
| 3 | 方盛制药 | 9.79% | -1.29% | 6.7分 |
| 4 | 信邦制药 | 8.86% | 1.55% | 6.1分 |
| 5 | 吉林敖东 | 7.50% | -1.16% | 5.8分 |
| 6 | 马应龙 | 4.95% | -3.48% | 6.3分 |
| 8 | 粤万年青 | 4.25% | 6.28% | 6.4分 |
| 10 | 陇神戎发 | 3.10% | 3.10% | 6.4分 |
| 12 | 桂林三金 | 2.56% | 0.73% | 6.9分 |
| 14 | 启迪药业 | 2.26% | 12.41% | 5.9分 |
| 16 | 江中药业 | 1.87% | 0.00% | 6.5分 |
| 18 | 嘉应制药 | 1.09% | -0.31% | 6.1分 |
| 20 | 羚锐制药 | 0.97% | 0.31% | 6.7分 |
| 22 | 白云山 | 0.63% | -0.08% | 6.3分 |
| 24 | 佐力药业 | 0.50% | -5.07% | 5.5分 |
| 26 | 亚宝药业 | 0.15% | -0.58% | 6.1分 |
| 28 | 汉森制药 | 0.00% | 2.76% | 6.1分 |
| 30 | 千金药业 | -0.28% | 1.23% | 6.7分 |
| 32 | 昆药集团 | -0.49% | -0.07% | 6.0分 |
| 34 | 盘龙药业 | -0.95% | 3.13% | 6.2分 |
| 36 | 红日药业 | -1.03% | 1.06% | 6.2分 |
| 38 | 广誉远 | -1.17% | 0.16% | 6.7分 |
| 40 | 上海凯宝 | -1.59% | 0.98% | 5.7分 |
| 42 | 中恒集团 | -1.72% | 1.42% | 6.3分 |
| 44 | 葵花药业 | -1.76% | 0.39% | 5.4分 |
| 46 | 华神科技 | -1.95% | 5.51% | 6.3分 |
| 48 | 太龙药业 | -2.51% | -0.15% | 6.0分 |
| 50 | 济川药业 | -2.69% | -1.65% | 6.2分 |
| 52 | 珍宝岛 | -2.80% | -1.91% | 5.5分 |
| 54 | 同仁堂 | -3.08% | -1.53% | 5.2分 |
| 56 | 寿仙谷 | -3.70% | -1.44% | 6.2分 |
| 58 | 康惠股份 | -5.20% | 4.91% | 5.4分 |
| 60 | 新天药业 | -5.34% | 0.37% | 5.8分 |
| 62 | 九芝堂 | -6.16% | -2.17% | 5.9分 |
| 64 | - | -6.76% | 0.78% | 分 |
| 66 | 贵州三力 | -7.50% | -1.97% | 5.7分 |
| 68 | 片仔癀 | -9.28% | -8.00% | 5.3分 |
| 70 | ST香雪 | -13.75% | -8.33% | 3.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 2/110 ， 49/110。
[{"date":"2025-06-30","value":"17.82","vol":"3.94"},{"date":"2025-03-31","value":"9.27","vol":"2.20"},{"date":"2024-12-31","value":"34.06","vol":"4.81"},{"date":"2024-09-30","value":"-10.47","vol":"2.92"},{"date":"2024-06-30","value":"-66.34","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
17.82 | 9.27 | 34.06 | -10.47 | -66.34 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"42.13","vol":"52.43"},{"date":"2025-03-31","value":"40.94","vol":"52.92"},{"date":"2024-12-31","value":"47.38","vol":"52.40"},{"date":"2024-09-30","value":"42.76","vol":"52.75"},{"date":"2024-06-30","value":"27.02","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
42.13 | 40.94 | 47.38 | 42.76 | 27.02 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 1/110 ， 6/110。
[{"date":"2025-06-30","value":"73.97","vol":"-6.98"},{"date":"2025-03-31","value":"88.55","vol":"-6.63"},{"date":"2024-12-31","value":"78.44","vol":"-6.97"},{"date":"2024-09-30","value":"44.80","vol":"-4.57"},{"date":"2024-06-30","value":"16.87","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
73.97 | 88.55 | 78.44 | 44.80 | 16.87 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"155.39","vol":"2.33"},{"date":"2025-03-31","value":"152.40","vol":"-36.42"},{"date":"2024-12-31","value":"139.83","vol":"-142.71"},{"date":"2024-09-30","value":"86.54","vol":"63.06"},{"date":"2024-06-30","value":"21.01","vol":"-13.80"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
155.39 | 152.40 | 139.83 | 86.54 | 21.01 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.80 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 31/110 ， 28/110。
[{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.12","vol":"0.12"},{"date":"2024-12-31","value":"0.55","vol":"0.49"},{"date":"2024-09-30","value":"0.35","vol":"0.37"},{"date":"2024-06-30","value":"0.18","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.12 | 0.55 | 0.35 | 0.18 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.22","vol":"1.17"},{"date":"2025-03-31","value":"0.56","vol":"0.60"},{"date":"2024-12-31","value":"2.40","vol":"2.40"},{"date":"2024-09-30","value":"1.59","vol":"1.79"},{"date":"2024-06-30","value":"0.90","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.22 | 0.56 | 2.40 | 1.59 | 0.90 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 60/110 ， 52/110。
[{"date":"2025-06-30","value":"-2.38","vol":"20.17"},{"date":"2025-03-31","value":"-18.46","vol":"0.38"},{"date":"2024-12-31","value":"2.46","vol":"15.45"},{"date":"2024-09-30","value":"-16.63","vol":"6.15"},{"date":"2024-06-30","value":"-77.18","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -2.38 | -18.46 | 2.46 | -16.63 | -77.18 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.32","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.93","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.43","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.32 | - | 0.93 | - | 0.43 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 43/110 ， 25/110。
[{"date":"2025-06-30","value":"0.79","vol":"2.88"},{"date":"2025-03-31","value":"0.80","vol":"2.97"},{"date":"2024-12-31","value":"0.78","vol":"2.86"},{"date":"2024-09-30","value":"0.65","vol":"3.22"},{"date":"2024-06-30","value":"0.74","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.79 | 0.80 | 0.78 | 0.65 | 0.74 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.57","vol":"2.11"},{"date":"2025-03-31","value":"0.56","vol":"2.20"},{"date":"2024-12-31","value":"0.58","vol":"2.09"},{"date":"2024-09-30","value":"0.42","vol":"2.40"},{"date":"2024-06-30","value":"0.47","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.57 | 0.56 | 0.58 | 0.42 | 0.47 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 43/110 ， 2/110。
[{"date":"2025-06-30","value":"76.97","vol":"33.91"},{"date":"2025-03-31","value":"79.55","vol":"33.34"},{"date":"2024-12-31","value":"80.74","vol":"34.08"},{"date":"2024-09-30","value":"84.57","vol":"32.93"},{"date":"2024-06-30","value":"87.65","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
76.97 | 79.55 | 80.74 | 84.57 | 87.65 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"4.97","vol":"0.74"},{"date":"2025-03-31","value":"5.95","vol":"0.72"},{"date":"2024-12-31","value":"6.80","vol":"0.74"},{"date":"2024-09-30","value":"9.26","vol":"3.16"},{"date":"2024-06-30","value":"15.67","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
4.97 | 5.95 | 6.80 | 9.26 | 15.67 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"-0.30","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.68","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.38","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.15","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]